If you have fatty liver disease, you can usually fly safely without restrictions. Fatty liver disease, or hepatic steatosis, affects around one in three UK adults, and most experience no symptoms that would prevent air travel. Simple fatty liver does not affect your ability to tolerate cabin pressure or pose immediate flight risks. However, if your condition has progressed to cirrhosis with complications such as ascites, varices, or hepatic encephalopathy, you should seek specialist advice before booking flights. This article explains when flying is safe, what precautions to take, and when medical clearance is necessary.

Can You Fly with Fatty Liver Disease?

The short answer is yes – most people with fatty liver disease can fly safely without special restrictions. Fatty liver disease, medically termed hepatic steatosis, is an extremely common condition affecting approximately one in three adults in the UK. The vast majority of individuals with this condition experience no symptoms and can undertake air travel without complications.

Non-alcoholic fatty liver disease (NAFLD) and its more advanced form, non-alcoholic steatohepatitis (NASH), typically do not pose direct contraindications to flying. The condition itself does not affect cabin pressure tolerance or create immediate health risks during flight. Unlike certain cardiovascular or respiratory conditions, uncomplicated fatty liver disease does not generally require special medical clearance for air travel.

However, the safety of flying depends significantly on the stage and severity of your liver condition. Simple hepatic steatosis (fat accumulation without inflammation) presents minimal concerns. Individuals with well-managed fatty liver disease who maintain regular medical follow-up can typically fly on both short-haul and long-haul routes without difficulty.

That said, complications arising from advanced liver disease – such as cirrhosis, portal hypertension, or decompensated liver function – require careful medical assessment before air travel. If your fatty liver has progressed to more serious liver disease with complications like ascites (fluid accumulation), varices (enlarged blood vessels), or hepatic encephalopathy (confusion due to liver dysfunction), you should seek specialist advice before booking flights.

Seek urgent medical help (contact your GP, call NHS 111, or dial 999 if severe) if you experience:

• Vomiting blood or passing black, tarry stools

• Severe abdominal pain or rapidly increasing abdominal swelling

• Yellowing of the skin or eyes (jaundice)

• Worsening confusion or drowsiness

• Severe breathlessness

The key consideration is not the fatty liver itself, but rather any associated complications that might be affected by the physiological stresses of air travel.

Understanding Fatty Liver and Air Travel Safety

Fatty liver disease exists on a spectrum from simple steatosis to advanced fibrosis and cirrhosis. Understanding where you sit on this spectrum is crucial for assessing air travel safety. Simple fatty liver involves fat accumulation in liver cells without significant inflammation or scarring. This early stage typically causes no symptoms and does not impair liver function, meaning air travel poses no additional risks beyond those faced by the general population.

The physiological environment during commercial flights includes reduced cabin pressure (equivalent to approximately 1,800–2,400 metres altitude) and lower humidity (typically 10–20%). For passengers with uncomplicated fatty liver disease, these factors present negligible risk. The liver continues to function normally during flight.

Non-alcoholic steatohepatitis (NASH) represents a more advanced stage where inflammation accompanies fat accumulation, potentially leading to progressive fibrosis. Even with NASH, if liver function remains preserved (normal synthetic function, no portal hypertension), flying is generally safe. Blood tests showing normal albumin, bilirubin, and clotting factors indicate adequate liver reserve for travel.

The primary concerns arise when fatty liver disease has progressed to cirrhosis with complications. Decompensated cirrhosis may involve:

• Ascites – abdominal fluid that, whilst not expanding at altitude, may cause increased discomfort as intestinal gas expands due to reduced cabin pressure

• Hepatic encephalopathy – confusion that may worsen with dehydration or constipation during travel

• Oesophageal varices – enlarged veins at risk of bleeding

• Coagulopathy – impaired clotting increasing bleeding risk

For most people with fatty liver disease diagnosed through routine blood tests or ultrasound, these complications are not present, and air travel remains entirely appropriate. If you have been diagnosed with cirrhosis or any of these complications, discuss travel plans with your hepatologist or specialist liver team.

When Flying May Be Unsafe with Liver Conditions

Whilst uncomplicated fatty liver disease does not preclude air travel, certain liver-related complications warrant careful consideration or may constitute relative contraindications to flying. Decompensated cirrhosis represents the primary concern, where the liver can no longer maintain essential functions.

Patients with tense ascites (significant abdominal fluid accumulation) may experience discomfort or respiratory compromise during flight. The reduced cabin pressure causes intestinal gas to expand, increasing abdominal distension and potentially compromising diaphragmatic movement. If you require regular large-volume paracentesis (fluid drainage), discuss timing with your hepatologist before travel.

Recent variceal bleeding or known large oesophageal or gastric varices present significant risk. If you have experienced variceal bleeding, you should seek specialist hepatology advice before undertaking air travel. Your specialist will ensure you have appropriate secondary prophylaxis (such as beta-blocker therapy) and that your condition is stable. The timing of travel after a bleeding episode should be individualised based on your clinical status and treatment.

Hepatic encephalopathy (grades 2–4) represents another contraindication. The confusion, altered consciousness, and potential for deterioration make air travel unsafe both for the patient and potentially disruptive for other passengers. Even grade 1 encephalopathy (mild confusion, altered sleep patterns) requires careful assessment, as dehydration and constipation during travel may precipitate worsening.

Additional concerning scenarios include:

• Recent liver biopsy – follow the advice of your hepatology team or the unit that performed the procedure; defer travel if any complications occur

• Acute hepatitis with severe symptoms or significantly elevated bilirubin

• Hepatorenal syndrome or other multi-organ involvement

• Awaiting urgent liver transplant assessment

If you have been hospitalised for liver-related complications within the past month, seek clearance from your hepatologist before flying. Airlines may request a medical certificate (Medical Information Form, or MEDIF) for passengers with significant medical conditions. Your GP or specialist can complete these forms if required.

Preparing for Air Travel with Fatty Liver

Proper preparation can ensure comfortable and safe air travel for individuals with fatty liver disease. Even with uncomplicated fatty liver, certain practical measures optimise your travel experience and minimise potential health risks.

Hydration is important. The low humidity in aircraft cabins accelerates fluid loss. Drink water regularly throughout the flight, avoiding excessive alcohol and caffeinated beverages which promote fluid loss. If you have cirrhosis with fluid restriction, discuss appropriate fluid intake with your specialist before travel.

Mobility and venous thromboembolism (VTE) prevention matter particularly for patients with liver disease. For flights exceeding four hours, follow NHS FitforTravel advice:

• Perform calf and ankle exercises every 30 minutes whilst seated

• Walk the cabin aisle regularly when safe to do so

• Consider well-fitted, below-knee graduated compression stockings (unless you have peripheral arterial disease or other contraindications)

• If you have additional VTE risk factors, discuss with your GP whether low-molecular-weight heparin is appropriate – this is reserved for very high-risk travellers after individual assessment

Note: Aspirin is not recommended for prevention of travel-related VTE.

Medication management requires planning. Carry all liver-related medications in hand luggage with original packaging and prescriptions. Common medications for fatty liver disease and associated conditions include:

• Statins for dyslipidaemia (continue as normal)

• Metformin or other diabetes medications (adjust timing for time zone changes)

• Vitamin E – if prescribed by your specialist for biopsy-proven NASH (this is an off-label use; your specialist will have discussed the potential risks and benefits with you)

For patients with cirrhosis, ensure adequate supplies of lactulose, rifaximin, beta-blockers, or diuretics as prescribed.

Dietary considerations include avoiding excessive sodium (which worsens fluid retention) and maintaining regular, balanced meals to support stable blood glucose – important as the liver regulates glucose metabolism.

Travel insurance is essential. Declare your fatty liver disease and any related conditions. Whilst simple fatty liver rarely affects premiums significantly, failure to disclose may invalidate claims. Ensure you have a valid UK Global Health Insurance Card (GHIC) or European Health Insurance Card (EHIC) if travelling within Europe, though this does not replace comprehensive travel insurance.

Note on compression stockings: These must be correctly fitted to be safe and effective. Seek advice from a pharmacist or healthcare professional if unsure about sizing or suitability.

Medical Advice Before Flying with Liver Disease

Determining whether you need formal medical clearance before flying depends on your liver disease severity and overall health status. For simple fatty liver disease identified through mildly elevated liver enzymes or ultrasound findings, with no symptoms and normal liver function tests, routine GP consultation is generally unnecessary specifically for travel clearance. However, if you have concerns or have not had recent medical review, a brief discussion with your GP can provide reassurance.

For patients with NASH, significant fibrosis, or cirrhosis, pre-travel medical consultation is advisable, particularly for long-haul flights or travel to destinations with limited medical facilities. Your GP or hepatologist can assess:

• Current liver function through blood tests (albumin, bilirubin, INR, platelets)

• Presence of complications such as ascites, encephalopathy, or varices

• Medication optimisation and supply adequacy

• Fitness to fly certification if required by airlines

The Model for End-Stage Liver Disease (MELD) score helps stratify disease severity. If you have moderate to severe liver disease (indicated by higher MELD scores or decompensated cirrhosis), seek specialist review before international travel to ensure your condition is stable and optimally managed.

Timing of medical review ideally occurs 2–4 weeks before departure, allowing time for any necessary investigations or treatment adjustments. Request a medical summary letter detailing your diagnosis, current medications, and recent investigations. This proves invaluable if you require medical attention abroad.

Consider asking your doctor about:

• Whether you need antibiotic prophylaxis for spontaneous bacterial peritonitis if you have ascites

• Adjusting diuretic doses for travel

• Carrying emergency contact details for hepatology services

• Vaccination requirements – consult NaTHNaC (TravelHealthPro) for destination-specific advice; some live vaccines may be contraindicated in certain liver conditions or if you are immunosuppressed

Airlines' medical clearance requirements vary. Most do not require documentation for stable, compensated liver disease, but may request a Frequent Traveller's Medical Card (FREMEC) or Medical Information Form (MEDIF) for passengers with significant medical conditions, supplemental oxygen requirements, or recent hospitalisation. Your GP or specialist can complete these forms.

Ultimately, open communication with your healthcare team ensures safe, enjoyable travel whilst managing your liver condition appropriately.

Reporting side effects: If you experience side effects from any medication, you can report these via the MHRA Yellow Card Scheme at https://yellowcard.mhra.gov.uk or search for 'MHRA Yellow Card' in the Google Play or Apple App Store.

Frequently Asked Questions